IMJUDO

Concentrate for solution for infusion, 20mg/ml
RxActive license

Active substance (INN)

tremelimumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength20mg/ml
PackagingUkupno 1 bočica staklena sa 15ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupAntineoplastic and immunomodulating agents (L01FX20)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 20, 2024

Analogs in Montenegro

1

Other medicines with the same active substance

IMJUDORx
Concentrate for solution for infusion, 20mg/mlAstraZeneca AB
Source: CInMED register